Cell Therapy Bioreactors Global Market Report 2026

Cell therapy bioreactors are specialized systems developed to enable the controlled cultivation, expansion, and differentiation of cells for therapeutic purposes. They maintain a controlled environment with accurate regulation of parameters such as temperature, pH, oxygen levels, and nutrient availability to preserve cell viability and functionality. By supporting scalable and consistent cell production, these bioreactors contribute to the development and manufacturing of advanced cell-based therapies.

The primary products in the cell therapy bioreactors market include stirred tank bioreactors, wave-induced bioreactors, fixed-bed bioreactors, and other products. Stirred tank bioreactors are systems in which cells are cultivated within a controlled liquid environment using mechanical agitation to maintain consistent mixing and promote uniform cell growth, whereas wave-induced bioreactors use controlled rocking motion to facilitate gentle mixing of cells and culture media. The cell types include stem cells, immune cells, differentiated cells, and others. The material types comprise single-use bioreactors and reusable bioreactor systems. These bioreactors support applications including research, clinical studies, and commercial production and are used by pharmaceutical and biotechnology companies, academic and research institutes, contract manufacturing organizations (CMOs), and other end users.

Tariffs have influencing the cell therapy bioreactor market by raising the costs of imported bioreactor components and culture media, which is affecting production schedules and supply chain efficiency. High tariffs particularly affect single-use and advanced automated systems imported into regions such as North America and Europe. Stem cell and immune cell production segments are experiencing considerable cost pressures, while local manufacturing initiatives may benefit from increased domestic demand. Overall, tariffs are encouraging the development of cost-effective manufacturing solutions and innovation while creating challenges for international suppliers.

The cell therapy bioreactors market research report is one of a series of new reports from The Business Research Company that provides cell therapy bioreactors market statistics, including cell therapy bioreactors industry global market size, regional shares, competitors with a cell therapy bioreactors market share, detailed cell therapy bioreactors market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy bioreactors industry. This cell therapy bioreactors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell therapy bioreactors market size has grown rapidly in recent years. It will grow from $1.24 billion in 2025 to $1.44 billion in 2026 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to increasing demand for cell-based therapeutic applications, growing investments in regenerative medicine, wider adoption of automated cell culture technologies, expansion of stem cell research activities, and rising requirements for scalable cell production capabilities.

The cell therapy bioreactors market size is expected to see rapid growth in the next few years. It will grow to $2.61 billion in 2030 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to increasing utilization of cell therapy bioreactors in manufacturing processes, rising investments in advanced bioprocessing technologies, greater emphasis on process optimization and quality assurance, expansion of clinical studies involving cell therapies, and growing demand for personalized medicine applications. Major trends in the forecast period include advancements in automated cell culture technologies, continued innovation in bioreactor designs to improve scalability, development of advanced stem cell expansion platforms, increasing research and development in process monitoring and control systems, and emergence of integrated solutions for cell therapy manufacturing.

The growing demand for gene therapies is expected to drive the growth of the cell therapy bioreactors market going forward. Gene therapy refers to a medical technique that involves modifying or replacing defective genes to treat or prevent diseases. The rising demand for gene therapy is attributed to advancements in genetic sequencing and diagnostics, which enable the precise identification of disease-causing genes for targeted treatment. Cell therapy bioreactors accelerate gene therapies by providing optimized environments for the growth, modification, and expansion of therapeutic cells. They support treatment development and scalability by ensuring consistent cell quality, enhancing efficiency, and enabling faster production of personalized gene-based therapies. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved 6 gene therapy products in 2023, compared with 5 approvals in 2022. Therefore, the growing demand for gene therapies is driving the growth of the cell therapy bioreactors market.

The increasing prevalence of chronic diseases is expected to drive the growth of the cell therapy bioreactors market going forward. Chronic and rare diseases refer to long-term health conditions and uncommon disorders that often require specialized treatment approaches, including personalized and regenerative therapies. The prevalence of chronic diseases is increasing largely due to unhealthy lifestyles, including poor diet, physical inactivity, and smoking, which increase the risk of conditions such as diabetes, heart disease, and obesity. Cell therapy bioreactors support chronic disease management by providing controlled environments for the cultivation and expansion of therapeutic cells. They improve treatment effectiveness and scalability by ensuring consistent cell quality, enabling personalized therapies, and supporting long-term patient care. For instance, in 2025, according to the International Diabetes Federation, a Belgium-based health organization, around 589 million adults aged 20-79 were living with diabetes in 2024, with the total number projected to reach 853 million by 2050. Therefore, the increasing prevalence of chronic and rare diseases is driving the growth of the cell therapy bioreactors market.

Key companies operating in the cell therapy bioreactors market are concentrating on developing advanced platforms, such as modular, multi-scale bioreactor platforms, to enhance process scalability, cell expansion efficiency, and consistency from early-stage research through commercial manufacturing. A modular multi-scale bioreactor platform refers to a flexible system that allows researchers to perform parallel small-scale experiments, optimize process conditions, and seamlessly scale up to mid- or large-scale production while maintaining consistent culture conditions and high yields. For example, in July 2024, EXO-Harvest, a Belgium-based biomanufacturing technology company, launched its advanced multi-scale bioreactor platform for the efficient manufacturing of mesenchymal stem cells and extracellular vesicles, supporting scalable adherent cell culture from discovery through industrial production. The platform includes small-scale multi-bioreactor screening capabilities as well as mid- and large-scale systems designed to accelerate development, reduce costs, and produce high-quality cultures with precise environmental control.

Major companies operating in the cell therapy bioreactors market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Holdings Corporation, Danaher Corporation, Corning Incorporated, Lonza Group, Terumo Corporation, Sartorius AG, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, PBS Biotech Inc., Meissner Filtration Products Inc., Infors AG, Bionet Engineering & Technologies Pvt. Ltd., Wilson Wolf Manufacturing Corporation, Synthecon Incorporated, Cellexus Limited, Celartia Inc., Able Biott Inc., CelVivo ApS

North America was the largest region in the cell therapy bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy bioreactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell therapy bioreactors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell therapy bioreactors market consists of sales of bioreactor vessels, control systems, single-use bioreactor units, perfusion bioreactors, and monitoring and automation equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Therapy Bioreactors Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cell therapy bioreactors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell therapy bioreactors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell therapy bioreactors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Stirred Tank Bioreactors; Wave-Induced Bioreactors; Fixed-Bed Bioreactors; Other Products
• 2) By Cell Type: Stem Cells; Immune Cells; Differentiated Cells; Other Cell Types
• 3) By Material: Single-Use Bioreactors; Reusable Bioreactors
• 4) By Application: Research; Clinical; Commercial Production
• 5) By End-Users: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Manufacturing Organizations (CMOs); Other End Users
• Subsegments:
• 1) By Stirred Tank Bioreactors: Stainless Steel Stirred Tank Systems; Glass Stirred Tank Systems; Single Use Stirred Tank Systems; Automated Stirred Tank Systems
• 2) By Wave Induced Bioreactors: Rocking Motion Bioreactor Systems; Single Use Wave Bag Systems; Modular Wave Platform Systems; Automated Wave Based Culture Systems
• 3) By Fixed Bed Bioreactors: Packed Bed Bioreactor Systems; Scaffold Based Fixed Bed Systems; Microcarrier Based Fixed Bed Systems; Perfusion Enabled Fixed Bed Systems
• 4) By Other Products: Hollow Fiber Bioreactor Systems; Perfusion Bioreactor Systems; Rotary Cell Culture Systems; Microfluidic Bioreactor Systems
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; FUJIFILM Holdings Corporation; Danaher Corporation; Corning Incorporated; Lonza Group; Terumo Corporation; Sartorius AG; Eppendorf AG; Miltenyi Biotec B.V. & Co. KG; PBS Biotech Inc.; Meissner Filtration Products Inc.; Infors AG; Bionet Engineering & Technologies Pvt. Ltd.; Wilson Wolf Manufacturing Corporation; Synthecon Incorporated; Cellexus Limited; Celartia Inc.; Able Biott Inc.; CelVivo ApS
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.